Correction (DOI:10.1016/j.jaci.2009.06.009);Comèl-Netherton syndrome defined as primary immunodeficiency

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 3, 2009, Pages 536-543

  Renner, Ellen D ^a   Hartl, Dominik ^a   Rylaarsdam, Stacey ^b   Young, Marguerite L ^b   Monaco Shawver, Linda ^c   Kleiner, Gary ^d   Markert, M Louise ^e   Stiehm, E Richard ^f   Belohradsky, Bernd H ^a   Upton, Melissa P ^b   Torgerson, Troy R ^b   Orange, Jordan S ^c   Ochs, Hans D ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

atopic diathesis; bamboo hair; Com l Netherton syndrome; ichthyosis; immune deficiency; IVIG; LEKTI; NK cell cytotoxicity; selective antibody deficiency; SPINK5

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN; PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIOPHAGE PHI X 174; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMEL NETHERTON SYNDROME; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; LEKTI GENE; MALE; MEMORY CELL; NATURAL KILLER CELL; NETHERTON DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPINK5 GENE; SUBSTITUTION THERAPY;

EID: 69349094764     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.10.043     Document Type: Erratum

References (49)

1. Comel M. Ichthyosis linearis circumflexa. Dermatologica 98 (1949) 133-136
2. Netherton E.W. A case for diagnosis. AMA Arch Derm Syphilol 64 (1951) 84-85
3. Wilkinson R.D., Curtis G.H., and Hawk W.A. Netherton's disease; trichorrhexis invaginata (bamboo hair), congenital ichthyosiform erythroderma and the atopic diathesis: a histopathologic study. Arch Dermatol 89 (1964) 46-54
4. Chavanas S., Bodemer C., Rochat A., Hamel-Teillac D., Ali M., Irvine A.D., et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25 (2000) 141-142
5. Jones S.K., Thomason L.M., Surbrugg S.K., and Weston W.L. Neonatal hypernatraemia in two siblings with Netherton's syndrome. Br J Dermatol 114 (1986) 741-743
6. Netherton E.W. A unique case of trichorrhexis nodosa; bamboo hairs. AMA Arch Derm 78 (1958) 483-487
7. Smith D.L., Smith J.G., Wong S.W., and deShazo R.D. Netherton's syndrome: a syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 95 (1995) 116-123
8. Greene S.L., and Muller S.A. Netherton's syndrome: report of a case and review of the literature. J Am Acad Dermatol 13 (1985) 329-337
9. Van Gysel D., Koning H., Baert M.R., Savelkoul H.F., Neijens H.J., and Oranje A.P. Clinico-immunological heterogeneity in Comel-Netherton syndrome. Dermatology 202 (2001) 99-107
10. Judge M.R., Morgan G., and Harper J.I. A clinical and immunological study of Netherton's syndrome. Br J Dermatol 131 (1994) 615-621
11. Hachem J.P., Wagberg F., Schmuth M., Crumrine D., Lissens W., Jayakumar A., et al. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126 (2006) 1609-1621
12. Jayakumar A., Kang Y., Henderson Y., Mitsudo K., Liu X., Briggs K., et al. Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution. Arch Biochem Biophys 435 (2005) 89-102
13. Magert H.J., Kreutzmann P., Standker L., Walden M., Drogemuller K., and Forssmann W.G. LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance. Int J Biochem Cell Biol 34 (2002) 573-576
14. Stryk S., Siegfried E.C., and Knutsen A.P. Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome. Pediatr Dermatol 16 (1999) 19-22
15. Geha R.S., Notarangelo L.D., Casanova J.L., Chapel H., Conley M.E., Fischer A., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120 (2007) 776-794
16. Ming J.E., Stiehm E.R., and Graham Jr. J.M. Syndromes associated with immunodeficiency. Adv Pediatr 46 (1999) 271-351
17. Lee W.I., Torgerson T.R., Schumacher M.J., Yel L., Zhu Q., and Ochs H.D. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105 (2005) 1881-1890
18. den Dunnen J.T., and Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15 (2000) 7-12
19. Kimmig S., Przybylski G.K., Schmidt C.A., Laurisch K., Mowes B., Radbruch A., et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 195 (2002) 789-794
20. Agematsu K., Futatani T., Hokibara S., Kobayashi N., Takamoto M., Tsukada S., et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 103 (2002) 34-42
21. Comans-Bitter W.M., de Groot R., van den Beemd R., Neijens H.J., Hop W.C., Groeneveld K., et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr 130 (1997) 388-393
22. Shearer W.T., Rosenblatt H.M., Gelman R.S., Oyomopito R., Plaeger S., Stiehm E.R., et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112 (2003) 973-980
23. Cossarizza A., Poccia F., Agrati C., D'Offizi G., Bugarini R., Pinti M., et al. Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection. J Acquir Immune Defic Syndr 35 (2004) 213-222
24. Ochs H.D., Davis S.D., and Wedgwood R.J. Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest 50 (1971) 2559-2568
25. Orange J.S., Ramesh N., Remold-O'Donnell E., Sasahara Y., Koopman L., Byrne M., et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A 99 (2002) 11351-11356
26. Raghunath M., Tontsidou L., Oji V., Aufenvenne K., Schurmeyer-Horst F., Jayakumar A., et al. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol 123 (2004) 474-483
27. Finberg R.W., Newburger J.W., Mikati M.A., Heller A.H., and Burns J.C. Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood. J Pediatr 120 (1992) 376-380
28. Hausser I., and Anton-Lamprecht I. Severe congenital generalized exfoliative erythroderma in newborns and infants: a possible sign of Netherton syndrome. Pediatr Dermatol 13 (1996) 183-199
29. De Wolf K., Ferster A., Sass U., Andre J., Stene J.J., and Song M. Netherton's syndrome: a severe neonatal disease: a case report. Dermatology 192 (1996) 400-402
30. Hoeger P.H., Adwani S.S., Whitehead B.F., Finlay A.Y., and Harper J.I. Ichthyosiform erythroderma and cardiomyopathy: report of two cases and review of the literature. Br J Dermatol 139 (1998) 1055-1059
31. Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118 (2006) 3-21 quiz 2-3
32. Stiehm E.R., Ochs H.D., and Winkelstein J.A. Immunologic disorders in infants & children (2004), Elsevier Saunders, Philadelphia
33. Seyama K., Nonoyama S., Gangsaas I., Hollenbaugh D., Pabst H.F., Aruffo A., et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92 (1998) 2421-2434
34. Ochs H.D., Slichter S.J., Harker L.A., Von Behrens W.E., Clark R.A., and Wedgwood R.J. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 55 (1980) 243-252
35. Nonoyama S., Tsukada S., Yamadori T., Miyawaki T., Jin Y.Z., Watanabe C., et al. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia. J Immunol 161 (1998) 3925-3929
36. Ochs H.D., Nonoyama S., Zhu Q., Farrington M., and Wedgwood R.J. Regulation of antibody responses: the role of complement and adhesion molecules. Clin Immunol Immunopathol 67 (1993) S33-S40
37. Day N., Tangsinmankong N., Ochs H., Rucker R., Picard C., Casanova J.L., et al. Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses. J Pediatr 144 (2004) 524-526
38. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104 (2004) 3647-3654
39. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197 (2003) 939-945
40. Folster-Holst R., Swensson O., Stockfleth E., Monig H., Mrowietz U., and Christophers E. Comel-Netherton syndrome complicated by papillomatous skin lesions containing human papillomaviruses 51 and 52 and plane warts containing human papillomavirus 16. Br J Dermatol 140 (1999) 1139-1143
41. Krasagakis K., Ioannidou D.J., Stephanidou M., Manios A., Panayiotides J.G., and Tosca A.D. Early development of multiple epithelial neoplasms in Netherton syndrome. Dermatology 207 (2003) 182-184
42. Katugampola R.P., Finlay A.Y., Harper J.I., Dojcinov S., and Maughan T.S. Primary cutaneous CD30+ T-cell lymphoproliferative disorder following cardiac transplantation in a 15-year-old boy with Netherton's syndrome. Br J Dermatol 153 (2005) 1041-1046
43. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
44. Roda J.M., Parihar R., Lehman A., Mani A., Tridandapani S., and Carson III W.E. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol 177 (2006) 120-129
45. Chan A., Hong D.L., Atzberger A., Kollnberger S., Filer A.D., Buckley C.D., et al. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 179 (2007) 89-94
46. Orange J.S. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol 6 (2006) 399-409
47. Ochs H.D., and Thrasher A.J. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117 (2006) 725-738 quiz 39
48. Cooley S., Xiao F., Pitt M., Gleason M., McCullar V., Bergemann T.L., et al. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 110 (2007) 578-586
49. Gurcan H.M., and Ahmed A.R. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Ann Pharmacother 41 (2007) 812-823